Corticosteroid-Dependent Plasticity Mediates Compulsive Alcohol Drinking in Rats

Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituit...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 32; no. 22; pp. 7563 - 7571
Main Authors Vendruscolo, Leandro F., Barbier, Estelle, Schlosburg, Joel E., Misra, Kaushik K., Whitfield, Timothy W., Logrip, Marian L., Rivier, Catherine, Repunte-Canonigo, Vez, Zorrilla, Eric P., Sanna, Pietro P., Heilig, Markus, Koob, George F.
Format Journal Article
LanguageEnglish
Published United States Society for Neuroscience 30.05.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and consequent alterations in glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation drive compulsive alcohol drinking. Our results showed that rats exposed to alcohol vapor to the point of dependence displayed increased alcohol intake, compulsive drinking measured by progressive-ratio responding, and persistent alcohol consumption despite punishment, assessed by adding quinine to the alcohol solution, compared with control rats that were not exposed to alcohol vapor. No group differences were observed in the self-administration of saccharin-sweetened water. Acute alcohol withdrawal was accompanied by downregulated GR mRNA in various stress/reward-related brain regions [i.e., prefrontal cortex, nucleus accumbens (NAc), and bed nucleus of the stria terminalis (BNST)], whereas protracted alcohol abstinence was accompanied by upregulated GR mRNA in the NAc core, ventral BNST, and central nucleus of the amygdala. No significant alterations in MR mRNA levels were found. Chronic GR antagonism with mifepristone (RU38486) prevented the escalation of alcohol intake and compulsive responding induced by chronic, intermittent alcohol vapor exposure. Chronic treatment with mifepristone also blocked escalated alcohol drinking and compulsive responding during protracted abstinence. Thus, the GR system appears to be involved in the development of alcohol dependence and may represent a potential pharmacological target for the treatment of alcoholism.
AbstractList Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and consequent alterations in glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation drive compulsive alcohol drinking. Our results showed that rats exposed to alcohol vapor to the point of dependence displayed increased alcohol intake, compulsive drinking measured by progressive-ratio responding, and persistent alcohol consumption despite punishment, assessed by adding quinine to the alcohol solution, compared with control rats that were not exposed to alcohol vapor. No group differences were observed in the self-administration of saccharin-sweetened water. Acute alcohol withdrawal was accompanied by downregulated GR mRNA in various stress/reward-related brain regions [i.e., prefrontal cortex, nucleus accumbens (NAc), and bed nucleus of the stria terminalis (BNST)], whereas protracted alcohol abstinence was accompanied by upregulated GR mRNA in the NAc core, ventral BNST, and central nucleus of the amygdala. No significant alterations in MR mRNA levels were found. Chronic GR antagonism with mifepristone (RU38486) prevented the escalation of alcohol intake and compulsive responding induced by chronic, intermittent alcohol vapor exposure. Chronic treatment with mifepristone also blocked escalated alcohol drinking and compulsive responding during protracted abstinence. Thus, the GR system appears to be involved in the development of alcohol dependence and may represent a potential pharmacological target for the treatment of alcoholism.
Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and consequent alterations in glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation drive compulsive alcohol drinking. Our results showed that rats exposed to alcohol vapor to the point of dependence displayed increased alcohol intake, compulsive drinking measured by progressive-ratio responding, and persistent alcohol consumption despite punishment, assessed by adding quinine to the alcohol solution, compared with control rats that were not exposed to alcohol vapor. No group differences were observed in the self-administration of saccharin-sweetened water. Acute alcohol withdrawal was accompanied by downregulated GR mRNA in various stress/reward-related brain regions [i.e., prefrontal cortex, nucleus accumbens (NAc), and bed nucleus of the stria terminalis (BNST)], whereas protracted alcohol abstinence was accompanied by upregulated GR mRNA in the NAc core, ventral BNST, and central nucleus of the amygdala. No significant alterations in MR mRNA levels were found. Chronic GR antagonism with mifepristone (RU38486) prevented the escalation of alcohol intake and compulsive responding induced by chronic, intermittent alcohol vapor exposure. Chronic treatment with mifepristone also blocked escalated alcohol drinking and compulsive responding during protracted abstinence. Thus, the GR system appears to be involved in the development of alcohol dependence and may represent a potential pharmacological target for the treatment of alcoholism.Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and consequent alterations in glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation drive compulsive alcohol drinking. Our results showed that rats exposed to alcohol vapor to the point of dependence displayed increased alcohol intake, compulsive drinking measured by progressive-ratio responding, and persistent alcohol consumption despite punishment, assessed by adding quinine to the alcohol solution, compared with control rats that were not exposed to alcohol vapor. No group differences were observed in the self-administration of saccharin-sweetened water. Acute alcohol withdrawal was accompanied by downregulated GR mRNA in various stress/reward-related brain regions [i.e., prefrontal cortex, nucleus accumbens (NAc), and bed nucleus of the stria terminalis (BNST)], whereas protracted alcohol abstinence was accompanied by upregulated GR mRNA in the NAc core, ventral BNST, and central nucleus of the amygdala. No significant alterations in MR mRNA levels were found. Chronic GR antagonism with mifepristone (RU38486) prevented the escalation of alcohol intake and compulsive responding induced by chronic, intermittent alcohol vapor exposure. Chronic treatment with mifepristone also blocked escalated alcohol drinking and compulsive responding during protracted abstinence. Thus, the GR system appears to be involved in the development of alcohol dependence and may represent a potential pharmacological target for the treatment of alcoholism.
Author Whitfield, Timothy W.
Sanna, Pietro P.
Heilig, Markus
Vendruscolo, Leandro F.
Zorrilla, Eric P.
Koob, George F.
Barbier, Estelle
Misra, Kaushik K.
Rivier, Catherine
Repunte-Canonigo, Vez
Logrip, Marian L.
Schlosburg, Joel E.
Author_xml – sequence: 1
  givenname: Leandro F.
  surname: Vendruscolo
  fullname: Vendruscolo, Leandro F.
– sequence: 2
  givenname: Estelle
  surname: Barbier
  fullname: Barbier, Estelle
– sequence: 3
  givenname: Joel E.
  surname: Schlosburg
  fullname: Schlosburg, Joel E.
– sequence: 4
  givenname: Kaushik K.
  surname: Misra
  fullname: Misra, Kaushik K.
– sequence: 5
  givenname: Timothy W.
  surname: Whitfield
  fullname: Whitfield, Timothy W.
– sequence: 6
  givenname: Marian L.
  surname: Logrip
  fullname: Logrip, Marian L.
– sequence: 7
  givenname: Catherine
  surname: Rivier
  fullname: Rivier, Catherine
– sequence: 8
  givenname: Vez
  surname: Repunte-Canonigo
  fullname: Repunte-Canonigo, Vez
– sequence: 9
  givenname: Eric P.
  surname: Zorrilla
  fullname: Zorrilla, Eric P.
– sequence: 10
  givenname: Pietro P.
  surname: Sanna
  fullname: Sanna, Pietro P.
– sequence: 11
  givenname: Markus
  surname: Heilig
  fullname: Heilig, Markus
– sequence: 12
  givenname: George F.
  surname: Koob
  fullname: Koob, George F.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22649234$$D View this record in MEDLINE/PubMed
BookMark eNqNUUtPFTEYbQxGLuhfILN0M9c-pu00MSZkQMGgEJR102m_gWpve23nkvDv6Q2PqBtdfYvz-E7O2UM7MUVA6IDgJeGUvfv89fjq8vzbcLrEWKiW0CXFhL5Ai4qqlnaY7KAFphK3opPdLtor5QfGWGIiX6FdSkWnKOsW6GJIefY2lRly8q49gjVEB3FuLoIpFfHzXfMFnDczlGZIq_UmFH8LzWGw6SaF5ij7-NPH68bH5tLM5TV6OZlQ4M3j3UdXH4-_Dyft2fmn0-HwrLWcsLkVsmeyc8QAjMBGpUbWT4LKUTneCzFRsJa7EbjEDLNpmjjmnDquejupkTq2jz48-K434wqcrZGzCXqd_crkO52M138i0d_o63SrGZNcUFIN3j4a5PRrA2XWK18shGAipE3RhHMiaEf_h4pJz5jClFXqwe-xnvM8NV4J7x8INqdSMky6Vmxmn7Ypfaheejuwfh5YbwfWhOrtwFUu_pI_ffiH8B7ocKxJ
CitedBy_id crossref_primary_10_7554_eLife_90422_3
crossref_primary_10_3390_ijms17081271
crossref_primary_10_1111_gbb_12189
crossref_primary_10_1016_j_bcp_2013_07_007
crossref_primary_10_1016_j_neuropharm_2021_108617
crossref_primary_10_1016_j_neuropharm_2022_109309
crossref_primary_10_1186_s12888_016_0757_1
crossref_primary_10_1523_JNEUROSCI_0445_14_2014
crossref_primary_10_1016_j_neuropharm_2020_108337
crossref_primary_10_1007_s00213_015_4033_8
crossref_primary_10_1038_s41598_018_31921_5
crossref_primary_10_1371_journal_pone_0072979
crossref_primary_10_3389_fnbeh_2017_00046
crossref_primary_10_1016_j_neuropharm_2017_04_028
crossref_primary_10_1124_jpet_120_000169
crossref_primary_10_3389_fnbeh_2018_00257
crossref_primary_10_1007_s00213_015_3909_y
crossref_primary_10_1016_j_alcohol_2018_04_006
crossref_primary_10_1111_nyas_13989
crossref_primary_10_1016_j_neubiorev_2012_07_010
crossref_primary_10_3389_fpsyt_2016_00165
crossref_primary_10_1523_ENEURO_0153_18_2018
crossref_primary_10_1038_s41583_020_0378_z
crossref_primary_10_1523_JNEUROSCI_1673_18_2018
crossref_primary_10_1111_acer_13936
crossref_primary_10_1016_j_ynstr_2023_100539
crossref_primary_10_1111_acer_14900
crossref_primary_10_1016_j_neuropharm_2017_04_031
crossref_primary_10_1016_j_neuropharm_2017_04_032
crossref_primary_10_1016_j_alcohol_2022_09_006
crossref_primary_10_1016_j_neubiorev_2023_105427
crossref_primary_10_3390_brainsci12081042
crossref_primary_10_1093_alcalc_agz022
crossref_primary_10_2139_ssrn_4122362
crossref_primary_10_1016_j_neuropharm_2013_04_036
crossref_primary_10_1038_s41386_018_0055_3
crossref_primary_10_1007_s00424_013_1266_4
crossref_primary_10_1016_j_neures_2020_01_002
crossref_primary_10_1164_rccm_202108_1845ST
crossref_primary_10_1111_adb_12758
crossref_primary_10_1016_j_neuropharm_2021_108510
crossref_primary_10_1016_j_psyneuen_2017_06_006
crossref_primary_10_1016_j_neuropharm_2020_108438
crossref_primary_10_3390_ijms22063095
crossref_primary_10_3389_adar_2023_10871
crossref_primary_10_1523_JNEUROSCI_1395_16_2016
crossref_primary_10_1038_s41380_022_01501_1
crossref_primary_10_1093_alcalc_agaa068
crossref_primary_10_4103_NRR_NRR_D_24_00355
crossref_primary_10_1111_adb_13158
crossref_primary_10_1111_acer_14129
crossref_primary_10_1523_JNEUROSCI_4571_14_2015
crossref_primary_10_1523_JNEUROSCI_3302_14_2015
crossref_primary_10_3390_metabo13010062
crossref_primary_10_1016_j_pbb_2021_173290
crossref_primary_10_1007_s00213_024_06707_5
crossref_primary_10_32345_2664_4738_1_2021_01
crossref_primary_10_1016_j_alcohol_2013_05_003
crossref_primary_10_1111_adb_12187
crossref_primary_10_1007_s00213_018_4905_9
crossref_primary_10_1016_j_pharmthera_2017_11_007
crossref_primary_10_1016_j_alcohol_2019_01_006
crossref_primary_10_1016_j_neubiorev_2019_10_009
crossref_primary_10_1016_j_neuroscience_2015_02_043
crossref_primary_10_1093_cercor_bhy341
crossref_primary_10_1016_j_alcohol_2015_03_001
crossref_primary_10_1111_acer_15006
crossref_primary_10_3389_fnbeh_2022_821859
crossref_primary_10_1093_alcalc_agz054
crossref_primary_10_1007_s00213_017_4608_7
crossref_primary_10_1016_j_bbr_2021_113295
crossref_primary_10_1111_acer_12093
crossref_primary_10_1016_j_bcp_2015_07_038
crossref_primary_10_1146_annurev_pharmtox_010715_103143
crossref_primary_10_1016_j_neuroscience_2014_06_053
crossref_primary_10_1016_j_neuropharm_2019_107669
crossref_primary_10_1111_adb_12289
crossref_primary_10_1111_jnc_15342
crossref_primary_10_1016_j_neuropharm_2020_108396
crossref_primary_10_1007_s00213_014_3665_4
crossref_primary_10_1111_adb_13138
crossref_primary_10_1007_s00429_015_1163_z
crossref_primary_10_1111_acer_14260
crossref_primary_10_3389_fnbeh_2019_00292
crossref_primary_10_1016_j_alcohol_2013_08_006
crossref_primary_10_3390_brainsci10100682
crossref_primary_10_3389_fphar_2022_927703
crossref_primary_10_1016_j_cobeha_2016_10_006
crossref_primary_10_1038_npp_2017_105
crossref_primary_10_1111_adb_12150
crossref_primary_10_1016_j_neuropharm_2016_08_008
crossref_primary_10_1016_j_bbr_2014_06_003
crossref_primary_10_1016_j_neuropharm_2015_06_017
crossref_primary_10_1038_mp_2017_97
crossref_primary_10_1016_j_taap_2017_02_003
crossref_primary_10_1111_adb_12829
crossref_primary_10_1186_s13059_015_0593_5
crossref_primary_10_1124_pharmrev_120_000083
crossref_primary_10_3389_fpsyt_2019_00580
crossref_primary_10_1111_acer_12547
crossref_primary_10_1016_j_neuron_2013_06_006
crossref_primary_10_1016_j_pbb_2016_08_001
crossref_primary_10_1016_j_yfrne_2014_01_001
crossref_primary_10_1038_npp_2014_293
crossref_primary_10_1089_jcr_2013_0003
crossref_primary_10_1007_s00213_016_4484_6
crossref_primary_10_1038_tp_2013_70
crossref_primary_10_1111_gbb_12344
crossref_primary_10_1038_npp_2012_261
crossref_primary_10_1038_s41386_022_01497_w
crossref_primary_10_1016_j_pbb_2018_07_011
crossref_primary_10_1111_gbb_12349
crossref_primary_10_3109_10253890_2013_872617
crossref_primary_10_3390_ijms21124411
crossref_primary_10_1016_j_neuroscience_2020_04_033
crossref_primary_10_1016_j_alcohol_2018_02_002
crossref_primary_10_1007_s11062_013_9354_9
crossref_primary_10_1111_adb_12937
crossref_primary_10_1016_j_neuropharm_2022_108980
crossref_primary_10_1111_acer_13303
crossref_primary_10_1016_j_brainres_2016_01_049
crossref_primary_10_1038_tp_2016_13
crossref_primary_10_1016_j_pnpbp_2017_09_003
crossref_primary_10_1038_mp_2016_131
crossref_primary_10_1016_j_pharmthera_2022_108299
crossref_primary_10_1016_j_neulet_2017_04_063
crossref_primary_10_1002_jeab_834
crossref_primary_10_1007_s00213_018_4855_2
crossref_primary_10_1038_s41386_018_0101_1
crossref_primary_10_1016_j_ejphar_2014_11_044
crossref_primary_10_1016_j_biopsych_2020_08_027
crossref_primary_10_1016_j_bbr_2019_02_015
crossref_primary_10_1016_j_pbb_2018_03_001
crossref_primary_10_1111_adb_12125
crossref_primary_10_1016_j_pbb_2020_172880
crossref_primary_10_1016_j_neuropharm_2022_109044
crossref_primary_10_1016_j_addicn_2022_100028
crossref_primary_10_3390_ijms241512233
crossref_primary_10_1007_s10571_018_0614_5
crossref_primary_10_1016_j_addicn_2022_100057
crossref_primary_10_1016_j_tins_2018_08_005
crossref_primary_10_1016_j_cobeha_2016_11_004
crossref_primary_10_1007_s00213_021_05770_6
crossref_primary_10_1007_s00213_017_4556_2
crossref_primary_10_1016_j_neuropharm_2019_107857
crossref_primary_10_7554_eLife_90422
crossref_primary_10_1177_02698811241230255
crossref_primary_10_3109_15622975_2014_916414
crossref_primary_10_1016_j_nlm_2013_06_017
crossref_primary_10_1038_nrn_2016_67
crossref_primary_10_1097_FBP_0000000000000304
crossref_primary_10_1016_j_alcohol_2015_04_006
crossref_primary_10_1016_j_alcohol_2015_04_004
crossref_primary_10_1016_j_neuropharm_2023_109635
crossref_primary_10_3390_brainsci11010062
crossref_primary_10_1523_JNEUROSCI_4062_12_2013
crossref_primary_10_1111_adb_12342
crossref_primary_10_1080_00952990_2016_1197232
crossref_primary_10_1111_acer_13434
crossref_primary_10_1111_acer_13555
crossref_primary_10_1111_adb_12349
crossref_primary_10_3390_brainsci9120367
crossref_primary_10_1016_j_alcohol_2014_09_002
crossref_primary_10_1073_pnas_1506012113
crossref_primary_10_1016_j_brainres_2020_146921
crossref_primary_10_1186_s13293_021_00395_y
crossref_primary_10_4303_jdar_236039
crossref_primary_10_1016_j_conb_2013_03_006
crossref_primary_10_1002_jnr_24932
crossref_primary_10_1111_acer_14318
crossref_primary_10_1016_j_alcohol_2014_03_001
crossref_primary_10_1016_j_alcohol_2018_05_014
crossref_primary_10_1177_2470547017698140
crossref_primary_10_1016_j_nlm_2024_107944
crossref_primary_10_1016_j_ynstr_2024_100609
crossref_primary_10_1371_journal_pbio_2006421
crossref_primary_10_1016_j_neuropharm_2013_05_024
crossref_primary_10_1523_JNEUROSCI_1027_24_2024
crossref_primary_10_1016_j_neuropharm_2022_109074
crossref_primary_10_1038_s41380_024_02514_8
crossref_primary_10_3389_fnins_2022_858427
crossref_primary_10_1016_j_mcn_2015_03_008
crossref_primary_10_1016_j_drugalcdep_2015_06_018
crossref_primary_10_1016_j_physbeh_2015_05_034
crossref_primary_10_1016_j_biopsych_2014_09_008
crossref_primary_10_1007_s00429_014_0755_3
crossref_primary_10_1016_j_neubiorev_2018_09_008
crossref_primary_10_1016_j_drugalcdep_2012_12_017
crossref_primary_10_1523_JNEUROSCI_2466_16_2017
crossref_primary_10_1016_j_alcohol_2015_11_010
crossref_primary_10_3390_brainsci8070119
crossref_primary_10_1007_s00213_022_06192_8
crossref_primary_10_1038_s41380_022_01934_8
crossref_primary_10_1007_s00213_014_3623_1
crossref_primary_10_3390_ijms22084184
crossref_primary_10_1038_npp_2014_55
crossref_primary_10_1080_13543784_2018_1502269
crossref_primary_10_1016_j_neuroscience_2012_10_052
crossref_primary_10_1016_j_bbr_2022_114032
crossref_primary_10_1016_j_alcohol_2016_07_008
crossref_primary_10_1016_j_nbd_2022_105610
crossref_primary_10_1016_j_bbr_2012_12_035
crossref_primary_10_1016_j_ynstr_2023_100547
crossref_primary_10_1016_j_neubiorev_2018_09_010
crossref_primary_10_1016_j_physbeh_2018_04_001
crossref_primary_10_1111_acer_13923
crossref_primary_10_1038_npp_2014_20
crossref_primary_10_1016_j_alcohol_2025_03_003
crossref_primary_10_1111_acer_13484
crossref_primary_10_1016_j_neuropharm_2017_03_027
crossref_primary_10_1038_s41380_019_0449_6
crossref_primary_10_1007_s00213_020_05722_6
crossref_primary_10_1016_j_psc_2015_05_009
crossref_primary_10_1111_adb_12429
crossref_primary_10_1016_j_drugalcdep_2019_107657
crossref_primary_10_1016_j_neuropharm_2017_03_028
crossref_primary_10_1111_acer_12269
crossref_primary_10_1016_j_nlm_2024_107955
crossref_primary_10_1172_JCI79828
crossref_primary_10_1038_s41386_024_01988_y
crossref_primary_10_1016_j_celrep_2024_114474
crossref_primary_10_1038_s41386_019_0538_x
crossref_primary_10_3389_fphar_2014_00279
crossref_primary_10_1007_s00213_016_4257_2
Cites_doi 10.1021/bi901956s
10.1016/S0306-4530(97)00027-9
10.1016/j.cct.2009.03.001
10.1210/me.2002-0144
10.1007/s002130100773
10.1523/JNEUROSCI.17-22-08856.1997
10.1158/1541-7786.MCR-11-0423-T
10.1007/BF02805986
10.1080/10253890400019672
10.1111/j.1530-0277.2007.00456.x
10.1111/j.1530-0277.2007.00444.x
10.1016/j.brainresbull.2005.08.006
10.15288/jsa.2003.64.445
10.1097/00000374-199812000-00023
10.1111/j.1530-0277.2002.tb02448.x
10.1210/me.2007-0360
10.1097/01.ALC.0000145781.11923.4E
10.1210/me.2007-0219
10.1038/npp.2009.110
10.1152/physrev.00041.2006
10.1111/j.1530-0277.2008.00799.x
10.1016/S0022-3565(25)12130-7
10.1016/j.neuropharm.2011.11.006
10.1111/j.1460-9568.2007.05972.x
10.1016/S0022-3565(25)27369-4
10.1111/j.1460-9568.2008.06455.x
10.1038/npp.2011.268
10.1371/journal.pone.0009296
10.3109/07853899309147861
10.1210/me.2004-0528
10.1016/S0022-3565(24)37765-1
10.1111/j.1530-0277.2000.tb02036.x
10.1007/978-3-642-28720-6_129
10.1097/01.ALC.0000087581.13912.64
10.1038/sj.npp.1300884
10.1111/j.1530-0277.2000.tb01988.x
10.1001/archpsyc.1990.01810160025004
10.1523/JNEUROSCI.3136-11.2012
10.1007/BF02245190
10.1073/pnas.0402208101
10.1016/j.biopsych.2007.01.010
10.1074/jbc.M106033200
10.1016/j.lfs.2005.01.013
10.1016/j.psyneuen.2003.09.004
10.1111/j.1369-1600.2008.00131.x
10.1016/S0091-3057(02)00791-8
10.1038/npp.2009.209
10.1073/pnas.0130100100
10.1016/0022-4731(88)90133-1
10.1073/pnas.92.13.5880
10.1111/j.1530-0277.2006.00259.x
10.1210/en.2010-0266
10.1111/j.1530-0277.2008.00632.x
10.1001/archgenpsychiatry.2011.49
10.2217/fnl.10.14
10.1111/j.1601-183X.2007.00345.x
10.1210/en.2010-0832
10.1111/j.1530-0277.1986.tb05120.x
10.1016/j.tins.2007.06.006
10.1126/science.134.3483.943
10.1111/j.1530-0277.2009.01051.x
10.1038/nrn1683
10.1016/S0165-6147(97)01115-2
10.1016/S0893-133X(99)00167-0
10.1074/jbc.M110.193672
10.1523/JNEUROSCI.0736-05.2005
10.1016/S0303-7207(98)00208-1
10.1016/j.yfrne.2004.07.001
10.1038/220911a0
10.1111/j.1530-0277.2008.00678.x
10.1016/0166-4328(95)00131-C
10.1128/MCB.05866-11
10.1002/dev.20324
10.1074/jbc.274.2.1005
ContentType Journal Article
Copyright Copyright © 2012 the authors 0270-6474/12/327563-09$15.00/0 2012
Copyright_xml – notice: Copyright © 2012 the authors 0270-6474/12/327563-09$15.00/0 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
5PM
DOI 10.1523/JNEUROSCI.0069-12.2012
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList
MEDLINE - Academic
CrossRef
MEDLINE
Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 7571
ExternalDocumentID PMC3375621
22649234
10_1523_JNEUROSCI_0069_12_2012
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: GM085659
– fundername: NIAAA NIH HHS
  grantid: F32AA018914
– fundername: NIAAA NIH HHS
  grantid: T32AA007456
– fundername: NIAAA NIH HHS
  grantid: T32 AA007456
– fundername: NIAAA NIH HHS
  grantid: F32 AA018914
– fundername: NIAAA NIH HHS
  grantid: R01 AA017371
– fundername: NIAAA NIH HHS
  grantid: AA017371
– fundername: NIDA NIH HHS
  grantid: DA004043
– fundername: NIAAA NIH HHS
  grantid: P50 AA006420
– fundername: NIAAA NIH HHS
  grantid: AA006420
GroupedDBID ---
-DZ
-~X
.55
18M
2WC
34G
39C
3O-
53G
5GY
5RE
5VS
AAFWJ
AAJMC
AAYXX
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADCOW
ADHGD
AENEX
AETEA
AFCFT
AFOSN
AFSQR
AHWXS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HYE
H~9
KQ8
L7B
MVM
OK1
P0W
P2P
QZG
R.V
RHI
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
XJT
YBU
YHG
YKV
YNH
YSK
AFHIN
AIZTS
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7X8
7TK
5PM
ID FETCH-LOGICAL-c513t-678374d1aeebe3b99b38f627b9d5866f2ecc5dbe570303fff50552d598cf9b2d3
ISSN 0270-6474
1529-2401
IngestDate Thu Aug 21 18:28:26 EDT 2025
Fri Jul 11 12:25:17 EDT 2025
Thu Jul 10 22:01:14 EDT 2025
Wed Feb 19 02:35:46 EST 2025
Tue Jul 01 05:18:51 EDT 2025
Thu Apr 24 23:06:19 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 22
Language English
License https://creativecommons.org/licenses/by-nc-sa/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c513t-678374d1aeebe3b99b38f627b9d5866f2ecc5dbe570303fff50552d598cf9b2d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: L.F.V., E.P.Z., M.H., and G.F.K. designed research; L.F.V., E.B., J.E.S., K.K.M., T.W.W., M.L.L., V.R.-C., and P.P.S. performed research; L.F.V., E.B., C.R., V.R.-C., E.P.Z., P.P.S., M.H., and G.F.K. analyzed data; L.F.V., E.P.Z., M.H., and G.F.K. wrote the paper.
OpenAccessLink https://www.jneurosci.org/content/jneuro/32/22/7563.full.pdf
PMID 22649234
PQID 1018339023
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3375621
proquest_miscellaneous_1551624221
proquest_miscellaneous_1018339023
pubmed_primary_22649234
crossref_citationtrail_10_1523_JNEUROSCI_0069_12_2012
crossref_primary_10_1523_JNEUROSCI_0069_12_2012
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-05-30
2012-May-30
20120530
PublicationDateYYYYMMDD 2012-05-30
PublicationDate_xml – month: 05
  year: 2012
  text: 2012-05-30
  day: 30
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of neuroscience
PublicationTitleAlternate J Neurosci
PublicationYear 2012
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
References Fahlke (2023041303563928000_32.22.7563.16) 1996; 127
Peeters (2023041303563928000_32.22.7563.47) 2004; 7
Mantsch (2023041303563928000_32.22.7563.37) 1998; 287
2023041303563928000_32.22.7563.40
2023041303563928000_32.22.7563.41
2023041303563928000_32.22.7563.43
Rimondini (2023041303563928000_32.22.7563.54) 2003; 64
2023041303563928000_32.22.7563.48
2023041303563928000_32.22.7563.49
2023041303563928000_32.22.7563.44
2023041303563928000_32.22.7563.45
Nihalani (2023041303563928000_32.22.7563.42) 2007; 8
Oomen (2023041303563928000_32.22.7563.46) 2007; 26
2023041303563928000_32.22.7563.51
2023041303563928000_32.22.7563.52
2023041303563928000_32.22.7563.53
2023041303563928000_32.22.7563.10
2023041303563928000_32.22.7563.50
2023041303563928000_32.22.7563.4
2023041303563928000_32.22.7563.15
2023041303563928000_32.22.7563.59
2023041303563928000_32.22.7563.5
2023041303563928000_32.22.7563.6
2023041303563928000_32.22.7563.17
2023041303563928000_32.22.7563.7
2023041303563928000_32.22.7563.18
2023041303563928000_32.22.7563.11
2023041303563928000_32.22.7563.55
2023041303563928000_32.22.7563.1
2023041303563928000_32.22.7563.12
Heikinheimo (2023041303563928000_32.22.7563.22) 1993; 25
2023041303563928000_32.22.7563.2
2023041303563928000_32.22.7563.13
Roberts (2023041303563928000_32.22.7563.56) 1995; 275
2023041303563928000_32.22.7563.57
2023041303563928000_32.22.7563.3
2023041303563928000_32.22.7563.58
2023041303563928000_32.22.7563.8
2023041303563928000_32.22.7563.19
2023041303563928000_32.22.7563.9
2023041303563928000_32.22.7563.62
2023041303563928000_32.22.7563.63
2023041303563928000_32.22.7563.20
2023041303563928000_32.22.7563.64
2023041303563928000_32.22.7563.21
2023041303563928000_32.22.7563.65
2023041303563928000_32.22.7563.60
2023041303563928000_32.22.7563.61
2023041303563928000_32.22.7563.26
2023041303563928000_32.22.7563.27
2023041303563928000_32.22.7563.28
2023041303563928000_32.22.7563.29
2023041303563928000_32.22.7563.66
2023041303563928000_32.22.7563.23
2023041303563928000_32.22.7563.67
2023041303563928000_32.22.7563.24
2023041303563928000_32.22.7563.68
2023041303563928000_32.22.7563.25
2023041303563928000_32.22.7563.69
2023041303563928000_32.22.7563.73
2023041303563928000_32.22.7563.30
2023041303563928000_32.22.7563.74
2023041303563928000_32.22.7563.31
2023041303563928000_32.22.7563.75
2023041303563928000_32.22.7563.76
2023041303563928000_32.22.7563.70
2023041303563928000_32.22.7563.71
2023041303563928000_32.22.7563.72
Lee (2023041303563928000_32.22.7563.32) 1997; 17
2023041303563928000_32.22.7563.38
2023041303563928000_32.22.7563.39
Ellis (2023041303563928000_32.22.7563.14) 1966; 153
2023041303563928000_32.22.7563.33
2023041303563928000_32.22.7563.34
2023041303563928000_32.22.7563.35
2023041303563928000_32.22.7563.36
References_xml – ident: 2023041303563928000_32.22.7563.4
  doi: 10.1021/bi901956s
– ident: 2023041303563928000_32.22.7563.21
  doi: 10.1016/S0306-4530(97)00027-9
– ident: 2023041303563928000_32.22.7563.5
  doi: 10.1016/j.cct.2009.03.001
– ident: 2023041303563928000_32.22.7563.25
  doi: 10.1210/me.2002-0144
– ident: 2023041303563928000_32.22.7563.76
  doi: 10.1007/s002130100773
– volume: 17
  start-page: 8856
  year: 1997
  ident: 2023041303563928000_32.22.7563.32
  article-title: An initial, three-day-long treatment with alcohol induces a long-lasting phenomenon of selective tolerance in the activity of the rat hypothalamic-pituitary-adrenal axis
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.17-22-08856.1997
– ident: 2023041303563928000_32.22.7563.55
  doi: 10.1158/1541-7786.MCR-11-0423-T
– volume: 127
  start-page: 133
  year: 1996
  ident: 2023041303563928000_32.22.7563.16
  article-title: Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/BF02805986
– volume: 7
  start-page: 233
  year: 2004
  ident: 2023041303563928000_32.22.7563.47
  article-title: Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion
  publication-title: Stress
  doi: 10.1080/10253890400019672
– ident: 2023041303563928000_32.22.7563.75
  doi: 10.1111/j.1530-0277.2007.00456.x
– ident: 2023041303563928000_32.22.7563.33
  doi: 10.1111/j.1530-0277.2007.00444.x
– ident: 2023041303563928000_32.22.7563.44
  doi: 10.1016/j.brainresbull.2005.08.006
– volume: 64
  start-page: 445
  year: 2003
  ident: 2023041303563928000_32.22.7563.54
  article-title: A temporal threshold for induction of persistent alcohol preference: behavioral evidence in a rat model of intermittent intoxication
  publication-title: J Stud Alcohol
  doi: 10.15288/jsa.2003.64.445
– ident: 2023041303563928000_32.22.7563.28
  doi: 10.1097/00000374-199812000-00023
– ident: 2023041303563928000_32.22.7563.66
  doi: 10.1111/j.1530-0277.2002.tb02448.x
– ident: 2023041303563928000_32.22.7563.9
  doi: 10.1210/me.2007-0360
– ident: 2023041303563928000_32.22.7563.45
  doi: 10.1097/01.ALC.0000145781.11923.4E
– ident: 2023041303563928000_32.22.7563.6
  doi: 10.1210/me.2007-0219
– ident: 2023041303563928000_32.22.7563.31
  doi: 10.1038/npp.2009.110
– ident: 2023041303563928000_32.22.7563.38
  doi: 10.1152/physrev.00041.2006
– ident: 2023041303563928000_32.22.7563.26
  doi: 10.1111/j.1530-0277.2008.00799.x
– volume: 275
  start-page: 790
  year: 1995
  ident: 2023041303563928000_32.22.7563.56
  article-title: Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)12130-7
– ident: 2023041303563928000_32.22.7563.12
  doi: 10.1016/j.neuropharm.2011.11.006
– volume: 26
  start-page: 3395
  year: 2007
  ident: 2023041303563928000_32.22.7563.46
  article-title: Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2007.05972.x
– volume: 153
  start-page: 121
  year: 1966
  ident: 2023041303563928000_32.22.7563.14
  article-title: Effect of ethanol on plasma corticosterone levels
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)27369-4
– ident: 2023041303563928000_32.22.7563.52
  doi: 10.1111/j.1460-9568.2008.06455.x
– ident: 2023041303563928000_32.22.7563.62
  doi: 10.1038/npp.2011.268
– ident: 2023041303563928000_32.22.7563.67
  doi: 10.1371/journal.pone.0009296
– volume: 25
  start-page: 71
  year: 1993
  ident: 2023041303563928000_32.22.7563.22
  article-title: Dose-response relationships of RU 486
  publication-title: Ann Med
  doi: 10.3109/07853899309147861
– ident: 2023041303563928000_32.22.7563.40
  doi: 10.1210/me.2004-0528
– volume: 287
  start-page: 72
  year: 1998
  ident: 2023041303563928000_32.22.7563.37
  article-title: Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(24)37765-1
– ident: 2023041303563928000_32.22.7563.34
  doi: 10.1111/j.1530-0277.2000.tb02036.x
– ident: 2023041303563928000_32.22.7563.30
  doi: 10.1007/978-3-642-28720-6_129
– ident: 2023041303563928000_32.22.7563.2
  doi: 10.1097/01.ALC.0000087581.13912.64
– ident: 2023041303563928000_32.22.7563.17
  doi: 10.1038/sj.npp.1300884
– ident: 2023041303563928000_32.22.7563.50
  doi: 10.1111/j.1530-0277.2000.tb01988.x
– ident: 2023041303563928000_32.22.7563.1
  doi: 10.1001/archpsyc.1990.01810160025004
– ident: 2023041303563928000_32.22.7563.49
  doi: 10.1523/JNEUROSCI.3136-11.2012
– ident: 2023041303563928000_32.22.7563.15
  doi: 10.1007/BF02245190
– ident: 2023041303563928000_32.22.7563.71
  doi: 10.1073/pnas.0402208101
– ident: 2023041303563928000_32.22.7563.7
– ident: 2023041303563928000_32.22.7563.64
  doi: 10.1016/j.biopsych.2007.01.010
– ident: 2023041303563928000_32.22.7563.70
  doi: 10.1074/jbc.M106033200
– ident: 2023041303563928000_32.22.7563.8
  doi: 10.1016/j.lfs.2005.01.013
– ident: 2023041303563928000_32.22.7563.29
  doi: 10.1016/j.psyneuen.2003.09.004
– ident: 2023041303563928000_32.22.7563.65
  doi: 10.1111/j.1369-1600.2008.00131.x
– ident: 2023041303563928000_32.22.7563.36
  doi: 10.1016/S0091-3057(02)00791-8
– ident: 2023041303563928000_32.22.7563.35
  doi: 10.1038/npp.2009.209
– ident: 2023041303563928000_32.22.7563.60
  doi: 10.1073/pnas.0130100100
– ident: 2023041303563928000_32.22.7563.3
  doi: 10.1016/0022-4731(88)90133-1
– ident: 2023041303563928000_32.22.7563.61
  doi: 10.1073/pnas.92.13.5880
– ident: 2023041303563928000_32.22.7563.69
  doi: 10.1111/j.1530-0277.2006.00259.x
– ident: 2023041303563928000_32.22.7563.43
  doi: 10.1210/en.2010-0266
– ident: 2023041303563928000_32.22.7563.73
  doi: 10.1111/j.1530-0277.2008.00632.x
– ident: 2023041303563928000_32.22.7563.63
  doi: 10.1001/archgenpsychiatry.2011.49
– ident: 2023041303563928000_32.22.7563.11
  doi: 10.2217/fnl.10.14
– ident: 2023041303563928000_32.22.7563.27
  doi: 10.1111/j.1601-183X.2007.00345.x
– ident: 2023041303563928000_32.22.7563.59
  doi: 10.1210/en.2010-0832
– ident: 2023041303563928000_32.22.7563.58
  doi: 10.1111/j.1530-0277.1986.tb05120.x
– volume: 8
  start-page: 563
  year: 2007
  ident: 2023041303563928000_32.22.7563.42
  article-title: Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression
  publication-title: Curr Opin Investig Drugs
– ident: 2023041303563928000_32.22.7563.23
  doi: 10.1016/j.tins.2007.06.006
– ident: 2023041303563928000_32.22.7563.24
  doi: 10.1126/science.134.3483.943
– ident: 2023041303563928000_32.22.7563.20
  doi: 10.1111/j.1530-0277.2009.01051.x
– ident: 2023041303563928000_32.22.7563.10
  doi: 10.1038/nrn1683
– ident: 2023041303563928000_32.22.7563.48
  doi: 10.1016/S0165-6147(97)01115-2
– ident: 2023041303563928000_32.22.7563.57
  doi: 10.1016/S0893-133X(99)00167-0
– ident: 2023041303563928000_32.22.7563.68
  doi: 10.1074/jbc.M110.193672
– ident: 2023041303563928000_32.22.7563.53
  doi: 10.1523/JNEUROSCI.0736-05.2005
– ident: 2023041303563928000_32.22.7563.51
  doi: 10.1016/S0303-7207(98)00208-1
– ident: 2023041303563928000_32.22.7563.74
  doi: 10.1016/j.yfrne.2004.07.001
– ident: 2023041303563928000_32.22.7563.39
  doi: 10.1038/220911a0
– ident: 2023041303563928000_32.22.7563.19
  doi: 10.1111/j.1530-0277.2008.00678.x
– ident: 2023041303563928000_32.22.7563.72
  doi: 10.1016/0166-4328(95)00131-C
– ident: 2023041303563928000_32.22.7563.18
  doi: 10.1128/MCB.05866-11
– ident: 2023041303563928000_32.22.7563.41
  doi: 10.1002/dev.20324
– ident: 2023041303563928000_32.22.7563.13
  doi: 10.1074/jbc.274.2.1005
SSID ssj0007017
Score 2.52416
Snippet Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 7563
SubjectTerms Alcohol Drinking - drug therapy
Alcohol Drinking - metabolism
Alcohol Drinking - pathology
Analysis of Variance
Animals
Behavior, Addictive - drug therapy
Behavior, Addictive - metabolism
Brain - metabolism
Central Nervous System Depressants - administration & dosage
Compulsive Behavior - physiopathology
Conditioning, Operant - drug effects
Ethanol - administration & dosage
Hormone Antagonists - therapeutic use
Male
Mifepristone - therapeutic use
Rats
Rats, Wistar
Receptors, Glucocorticoid - genetics
Receptors, Glucocorticoid - metabolism
Receptors, Mineralocorticoid - genetics
Receptors, Mineralocorticoid - metabolism
Reinforcement Schedule
RNA, Messenger - metabolism
Self Administration
Substance Withdrawal Syndrome - drug therapy
Substance Withdrawal Syndrome - metabolism
Up-Regulation - drug effects
Title Corticosteroid-Dependent Plasticity Mediates Compulsive Alcohol Drinking in Rats
URI https://www.ncbi.nlm.nih.gov/pubmed/22649234
https://www.proquest.com/docview/1018339023
https://www.proquest.com/docview/1551624221
https://pubmed.ncbi.nlm.nih.gov/PMC3375621
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgvPCCgPFRvmQkxAsKS-w4Th6natMYWwHRor5F-bIarSSoSR7gr-fOceKVFRi8RJWb1JHvfP2d7353hLxyCwANnqucVAlwULC1SSqZcgC5ZjxMlC91L4LzWXCy8E-XYmlTgjS7pE3fZj928kr-R6owBnJFluw_SHb8URiAzyBfuIKE4XotGU9rHEOaxqYuc2doaNtib2isv4wIW1ND8HAVk8e7tc5WT_q-uG_yTd85QZNakr6m04BULWdMo9VLdS9HVfgCs226Butea_e-SLD6gc0VxlhGafg0jWar2LDPal03GOHpT_CLtWVEnJfNxvDUumZVXpiDWHMygSkeYgiyGGPKdPSm151ix5ixwPaEsxtoysaeStGbvyuGXuiCE6czzHf8PH2H6XnY1gFz9Zj9axvC-bMP8fHi7CyeHy3nN8ktBi4F2sT3n2xleenq7szj-xk2OcxzsHuWbSBzxTv5Ncn2EmqZ3yV3jADpYa8798iNorpP9g-rpK2_fqevqU4A1pGVffLxd-pErTrRQZ2oVSdq1IkO6kTLiqI6PSCL46P59MQxDTecTHi8dQC4cOnnXlLA1uZpFKU8VAGTaZSLMAgUg_0u8rTAqm0uV0oBfBYsF1GYqShlOX9I9qq6Kh4TKn0lw8D1E-4mfu5KcFsFeBuJZCJLXakmRAyrF2emGj02RVnH6JXCqsfjqse46rHHYlz1CTkYn_vW12P56xMvB-HEYDoxHpZURd01mN0Ych4Bav3DPRhIBhjLvAl51At0nBc56OAf-RMit0Q93oCl27e_qcqVLuHOOWg2855c492ektt2cz0je-2mK54DEG7TF1qDfwIr0rVU
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corticosteroid-dependent+plasticity+mediates+compulsive+alcohol+drinking+in+rats&rft.jtitle=The+Journal+of+neuroscience&rft.au=Vendruscolo%2C+Leandro+F&rft.au=Barbier%2C+Estelle&rft.au=Schlosburg%2C+Joel+E&rft.au=Misra%2C+Kaushik+K&rft.date=2012-05-30&rft.issn=1529-2401&rft.eissn=1529-2401&rft.volume=32&rft.issue=22&rft.spage=7563&rft_id=info:doi/10.1523%2FJNEUROSCI.0069-12.2012&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon